Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Chakraborty, Suparna

  • Google
  • 2
  • 12
  • 16

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (2/2 displayed)

  • 2023Synthesis and in vitro anticancer studies of arene ruthenium(II) and arene osmium(II) complexes bearing arsine and stibine co-ligands on breast cancer cell-lines5citations
  • 2021Ionic Ruthenium and Iron Based Complexes Bearing Silver Containing Anions as a Potent New Class of Anticancer Agents11citations

Places of action

Chart of shared publication
Van Nuffel, Sebastiaan
1 / 4 shared
Marschner, Christoph
2 / 2 shared
Latis, Stefan
1 / 1 shared
Heeren, Ron
1 / 1 shared
Blom, Burgert
2 / 4 shared
Baumgartner, Judith
1 / 2 shared
Prince, Sharon
2 / 2 shared
Garcia, Kimberly G.
1 / 1 shared
Biswas, Supratim
2 / 2 shared
Vieru, Veacheslav
1 / 3 shared
Benamrane, Amal
1 / 2 shared
Herry, Brian
1 / 2 shared
Chart of publication period
2023
2021

Co-Authors (by relevance)

  • Van Nuffel, Sebastiaan
  • Marschner, Christoph
  • Latis, Stefan
  • Heeren, Ron
  • Blom, Burgert
  • Baumgartner, Judith
  • Prince, Sharon
  • Garcia, Kimberly G.
  • Biswas, Supratim
  • Vieru, Veacheslav
  • Benamrane, Amal
  • Herry, Brian
OrganizationsLocationPeople

article

Ionic Ruthenium and Iron Based Complexes Bearing Silver Containing Anions as a Potent New Class of Anticancer Agents

  • Marschner, Christoph
  • Vieru, Veacheslav
  • Benamrane, Amal
  • Blom, Burgert
  • Prince, Sharon
  • Chakraborty, Suparna
  • Herry, Brian
  • Biswas, Supratim
Abstract

<p>A series of salt complexes of the type [RuCl(eta(6)-arene)(kappa(2)-dppm)](+)[AgCl(hfac)(PMe3)](-)(arene = benzene (1a) or p-cymene (1b), hfac = hexafluoroacetylacetato, dppm = 1,1-bis(diphenylphosphino)methane) have been prepared in a facile route by reaction of [RuCl2(eta(6)-arene)(kappa(1)-dppm)] with [Ag(hfac)(PMe3)]. The iron complex: [CpFe(CO)(kappa(2)-dppm)](+) [AgI(hfac)(PMe3)](-) (4) (Cp = eta(5)-C5H5) was also isolated in an analogous fashion by reacting the known complex [CpFeI(CO)(kappa(1)-dppm)] with [Ag(hfac)(PMe3)]. The complexes were fully characterised by spectroscopic means including multinuclear NMR spectroscopy, IR, ESI-MS and UV-Vis. In all cases broad signals are observed in the P-31{H-1} NMR spectra corresponding to the P atom in the anion [AgX(hfac)(PMe3)](-) (X = Cl or I) which suggests fluxional behaviour. Confirming this picture, the single crystal X-ray diffraction analysis of [CpFe(CO)(kappa(2)-dppm)](+)[hfac](-) (4-D) is presented, obtained as a decomposition product of compound 4 corresponding with the loss of "AgI(PMe3)". The nature of the elusive anion [AgX(hfac)(PMe3)](-) was investigated by DFT methods (BP86 functional, the ma-def2-SVP basis set for all atoms) showing a weak interaction between the oxygen atoms of the hfac- moiety and the Ag centre. Calculated IR spectra were compared to those obtained experimentally and show an excellent agreement, confirming this picture. The in vitro cytotoxicity on two breast cancer cell-lines (MCF-7 and MDA-MB-231) of all compounds is reported and compared to cisplatin as positive control. The tetrafluoroborate complexes: type [RuCl(eta(6)-arene)(kappa(2)-dppm)]+BF4- (arene = benzene (2a) or p-cymene (2b)) were also prepared and tested in order to elucidate the effect of the silver anion on cytotoxicity and selectivity in 1a and 1b . Moreover, the complex [CpFe(CO)(kappa(2)-dppm)]+BF4- (3) was also prepared for comparison to 4 , bearing the silver anion. In general, all complexes exhibit remarkable cytotoxicity and selectivity profiles on both cell-lines, and out-perform cisplatin. The presence of silver in the anion (in compounds 1a, 1b and 4) on average enhance their cytotoxicity compared to their corresponding BF4 analogues. The most active and selective in the entire series is compound 4 , which demonstrates that these compounds represent high potential in anticancer applications. Moreover, compounds 4 and 1a inhibited the long-term survival and migration of oestrogen receptor positive (MCF-7) and triple negative (MDA-MB-231) breast cancer cell lines tested respectively. Additionally, compounds 4 and 1a induced morphological and molecular characteristics of apoptosis in MCF-7 and MDA-MB-231 breast cancer cells respectively. (C) 2020 Elsevier B.V. All rights reserved.</p>

Topics
  • impedance spectroscopy
  • compound
  • single crystal X-ray diffraction
  • single crystal
  • silver
  • Oxygen
  • density functional theory
  • iron
  • Nuclear Magnetic Resonance spectroscopy
  • decomposition
  • Ruthenium
  • electrospray ionisation
  • electrospray ionisation mass spectrometry